Structure | Chemical Name | CAS | MF |
|
PROTEIN KINASE C DELTA PEPTIDE
|
163751-36-8
|
C77H113N17O22
|
|
Disperse orange 31:1
|
163751-76-6
|
|
|
2'-O-(2-Methoxyethyl)-5-methyluridine
|
163759-49-7
|
C13H20N2O7
|
|
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-5-methyluridine
|
163759-50-0
|
C34H38N2O9
|
|
DMT-2′O-MOE-rMeC(bz) Phosphoramidite
|
163759-94-2
|
C50H60N5O10P
|
|
DMT-2'-O-MOE-rU Phosphoramidite
|
163759-97-5
|
C42H53N4O10P
|
|
(R)-1-Boc-3-methylpiperazine
|
163765-44-4
|
C10H20N2O2
|
|
Auristatin F
|
163768-50-1
|
C40H67N5O8
|
|
N-(2,2-DIMETHOXYETHYL)TRICHLOROACETAMIDINE
|
163769-72-0
|
C6H11Cl3N2O2
|
|
5,6-DIHYDRO-2,3-DIMETHOXY-6,6-DIMETHYLBENZ[7,8]INDOLIZINO[2,3-B]QUINOXALINE
|
163769-88-8
|
C22H21N3O2
|
|
l-Threitol, 2-O-nonyl-
|
163776-15-6
|
C13H28O4
|
|
METHYL-2,3,4-TRI-O-ACETYL-BETA-D-GALACTOPYRANOSYLURONOSYL AZIDE
|
163776-36-1
|
C13H17N3O9
|
|
4-Pyridinecarboxylicacidcyclooctylester
|
163778-03-8
|
C14H19NO2
|
|
4-Pyridinecarboxylicacidcyclohexylester
|
163778-04-9
|
C12H15NO2
|
|
3-CYANOPROPYL(DIISOPROPYL)DIMETHYLAMINOSILANE
|
163794-91-0
|
C12H26N2Si
|
|
SYBR(R) GREEN I NUCLEIC ACID GEL STAIN
|
163795-75-3
|
C32H37N4S
|
|
tert-butyl 2-(chloromethyl)-1H-benzimidazole-1-carboxylate
|
163798-87-6
|
C13H15ClN2O2
|
|
4-[4-(BROMOMETHYL)PHENYL]-1,2,3-THIADIAZOLE
|
163798-92-3
|
C9H7BrN2S
|
|
PHENYL N-[2-(DIMETHYLAMINO)ETHYL]CARBAMATE HYDROCHLORIDE
|
163799-67-5
|
C11H17ClN2O2
|
|
Dodecanedioic acid polymer with 4,4`-methylenebis [2-methyl cyclohexanamine]
|
163800-66-6
|
C27H52N2O4
|
|
Polyimino(2-methyl-1,4-cyclohexanediyl)methylene(3-methyl-1,4-cyclohexanediyl)imino(1,12-dioxo-1,12-dodecanediyl)
|
163800-67-7
|
|
|
2(1H)-Pyridinone,4-hydroxy-5,6-dimethyl-3-nitro-
|
163803-34-7
|
C7H8N2O4
|
|
Pyrazolidine, 4-bromo- (9CI)
|
163805-06-9
|
C3H7BrN2
|
|
Cyanamide, [4-(1-methylethyl)phenyl]- (9CI)
|
163805-10-5
|
C10H12N2
|
|
1H-Benzimidazol-4-ol,1-methyl-
|
163808-08-0
|
C8H8N2O
|
|
4-AMINOBENZOOXAZOL
|
163808-09-1
|
C7H6N2O
|
|
4-NITRO-1,3-BENZOXAZOLE
|
163808-13-7
|
C7H4N2O3
|
|
4-Methoxy Retinoic Acid Methyl Ester
|
163808-81-9
|
C22H32O3
|
|
(R)-4-BENZYL-3-(4-METHYL-PENTANOYL)-OXAZOLIDIN-2-ONE
|
163810-26-2
|
C16H21NO3
|
|
3-(2-Bromo-Phenyl)-N-Methyl-Propionamide(WX633150)
|
163810-49-9
|
C10H12BrNO
|
|
[S-(E)]-2-(methoxydiphenylmethyl)-1-(2-nitroethenyl)-pyrrolidine
|
163814-41-3
|
C20H22N2O3
|
|
1,6,7,8-Indolizinetetrol, octahydro-, 6-(dihydrogen phosphate), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
|
163814-80-0
|
C8H16NO7P
|
|
7β-Hydroxyrutaecarpine
|
163815-35-8
|
C18H13N3O2
|
|
(R)-(-)-N-BENZYL-1-(1-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE
|
163831-65-0
|
C19H20ClN
|
|
(S)-N-BENZYL-1-(1-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE
|
163831-66-1
|
C19H20ClN
|
|
Pyridinium, 1-2-ethyl4-4-4-4-ethyl(2-pyridinioethyl)amino-2-methylphenylazobenzoylaminophenylazo-3-methylphenylaminoethyl-, dichloride
|
163831-67-2
|
C45H49Cl2N9O
|
|
5(6)-CARBOXYNAPHTHOFLUORESCEIN DIACETATE
|
163831-68-3
|
C33H20O9
|
|
Oxazolo[2,3,4-cd]pyrrolizine (9CI)
|
163831-74-1
|
C8H5NO
|
|
antigen LACK
|
163832-69-7
|
|
|
(S)-p-Chlorophenyl-phenylMethanaMine
|
163837-32-9
|
C13H12ClN
|
|
mecilizine hydrochloride
|
163837-33-0
|
C25H28Cl2N2
|
|
mecilizine hydrochloride
|
163837-34-1
|
C25H29Cl3N2
|
|
hydroxyzine hydrochloride
|
163837-37-4
|
C21H28Cl2N2O2
|
|
hydroxyzine hydrochloride
|
163837-38-5
|
C21H28Cl2N2O2
|
|
(S)-Cetirizine Dihydrochloride
|
163837-48-7
|
C21H26Cl2N2O3
|
|
mecilizine
|
163837-49-8
|
C25H27ClN2
|
|
mecilizine
|
163837-50-1
|
C25H27ClN2
|
|
1-[(4-CHLOROPHENYL)(PHENYL)METHYL]-4-[(4-METHYLPHENYL)SULFONYL]PIPERAZINE
|
163837-56-7
|
C24H25ClN2O2S
|
|
(-)-4-Chlorobenzhydrylamine
|
163837-57-8
|
C13H12ClN
|
|
tert-butyl 4-isonicotinoylpiperazine-1-carboxylate
|
163838-89-9
|
C15H21N3O3
|
|
Piperazine, 1-(3-thienylmethyl)-, hydrochloride (1:1)
|
163839-04-1
|
C9H15ClN2S
|
|
Acetic acid, [4-(trifluoroMethyl)phenoxy]-
|
163839-73-4
|
C9H7F3O3
|
|
TAPI-1
|
163847-77-6
|
C26H37N5O5
|
|
3,4-DIFLUOROPHENETOLE
|
163848-46-2
|
C8H8F2O
|
|
2-Buten-1-one,3-amino-1-(1-methyl-2-pyrrolidinyl)-,(S)-(9CI)
|
163849-05-6
|
C9H16N2O
|
|
2-Pyrrolidinone,5-(3-methyl-5-isoxazolyl)-,(S)-(9CI)
|
163849-08-9
|
C8H10N2O2
|
|
2-Pyrrolidinepropanenitrile,1-methyl--bta--oxo-,(S)-(9CI)
|
163849-09-0
|
C8H12N2O
|
|
Methanimidamide, N-(2-cyanoethenyl)-N,N-dimethyl- (9CI)
|
163852-01-5
|
C6H9N3
|
|
2-Butynoicacid,4-[[(1,1-dimethylethoxy)carbonyl]amino]-,methylester(9CI)
|
163852-55-9
|
C10H15NO4
|
|
Cyclopentanol, 2-(1-fluoro-1-methylethyl)-5-methyl-, (1-alpha-,2-ba-,5-alpha-)- (9CI)
|
163852-74-2
|
C9H17FO
|
|
1,4-Oxathiin-3-carboxylicacid,6-ethoxy-5,6-dihydro-2-methyl-,methylester(9CI)
|
163852-89-9
|
C9H14O4S
|
|
BCAT
|
163853-10-9
|
C14H15N5O3S
|
|
Propanamide, N-(2-phenylethenyl)-
|
163853-25-6
|
C11H13NO
|
|
4-Iodo-1-tosyl-1H-imidazole
|
163854-63-5
|
C10H9IN2O2S
|
|
2,5-Furandicarboxaldehyde, radical ion(1-) (9CI)
|
163857-09-8
|
C6H4O3
|
|
5-fluoro-3-(3-(piperazin-1-yl)propyl)-1H-indole
|
163860-25-1
|
C15H20FN3
|
|
(1R,2R)-ethyl 2-((R)-1-phenylethylaMino)cyclopentanecarboxylate hydrochloride
|
163877-11-0
|
C16H23NO2
|
|
3,6-BIS[(CHLOROCARBONYL)OXY]HEXAHYDROFURO[3,2-B]FURAN
|
163877-37-0
|
C8H8Cl2O6
|
|
D-Galactitol, 2-deoxy-2-(1,1-dimethylethoxy)carbonylamino-5,6-O-(1-methylethylidene)-3-O-(phenylmethyl)-1-O-(triphenylmethyl)-
|
163877-39-2
|
C40H47NO7
|
|
D-Galactitol, 2-deoxy-2-(1,1-dimethylethoxy)carbonylamino-5,6-O-(1-methylethylidene)-3-O-(phenylmethyl)-
|
163877-40-5
|
C21H33NO7
|
|
D-Galactitol, 2-deoxy-2-(1,1-dimethylethoxy)carbonylamino-5,6-O-(1-methylethylidene)-3-O-(phenylmethyl)-, 1,4-dimethanesulfonate
|
163877-41-6
|
C23H37NO11S2
|
|
Acetamide, N-5-(1,2-dihydroxyethyl)-4-hydroxy-3-pyrrolidinyl-, monohydrochloride, 3S-3.alpha.,4.beta.,5.beta.(R*)-
|
163877-42-7
|
C8H17ClN2O4
|
|
Cyclopropanecarbonyl chloride, 3-(2-chloro-2-fluoroethenyl)-2,2-dimethyl-, (1R-trans)- (9CI)
|
163877-51-8
|
C8H9Cl2FO
|
|
2'-O-MOE-5MeU-3'-phosphoramidite
|
163878-63-5
|
C43H55N4O10P
|
|
A mixture of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid
|
163879-69-4
|
|
|
Benzenesulfonic acid, 5-chloro-2-1-(2-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-ylazo-4-methyl-, sodium salt
|
163879-73-0
|
|
|
2-Naphthalenecarboxamide, 4-4-(aminocarbonyl)phenylazo-3-hydroxy-N-(3-nitrophenyl)-
|
163879-74-1
|
C24H17N5O5
|
|
Magnesium, bis5-chloro-2-1-(2-chlorophenyl)-4,5-dihydro-3-methyl-5-(oxo-.kappa.O)-1H-pyrazol-4-ylazo-.kappa.N1-4-methylbenzenesulfonato-, (T-4)-
|
163879-75-2
|
C34H26Cl4MgN8O8S2
|
|
Ethanone, 2,2,2-trifluoro-1-(1H-inden-2-yl)- (9CI)
|
163882-68-6
|
C11H7F3O
|
|
3-Penten-2-one, 1,1,1-trifluoro-3,4-dimethyl-
|
163882-69-7
|
C7H9F3O
|
|
4-Penten-2-one, 1,1,1-trifluoro-3,4-dimethyl-
|
163882-70-0
|
C7H9F3O
|
|
Ethanone, 2,2,2-trifluoro-1-(2-methyl-1-cyclopenten-1-yl)- (9CI)
|
163882-71-1
|
C8H9F3O
|
|
Ethanone, 2,2,2-trifluoro-1-(2-methyl-1-cyclohexen-1-yl)- (9CI)
|
163882-72-2
|
C9H11F3O
|
|
Ethanone, 2,2,2-trifluoro-1-(2-methyl-2-cyclohexen-1-yl)- (9CI)
|
163882-73-3
|
C9H11F3O
|
|
Ethanone, 2,2,2-trifluoro-1-(2-methylenecyclohexyl)- (9CI)
|
163882-74-4
|
C9H11F3O
|
|
asoprisnil ecamate
|
163883-88-3
|
C31H40N2O5
|
|
FMOC-DL-(PHENYL)GLY-OH
|
163883-97-4
|
C23H19NO4
|
|
METHYL BROMOACETATE-2,2-D2
|
163886-16-6
|
C3H3BrD2O2
|
|
3-(5-bromo-1H-indol-3-yl)-N-methylsuccinimide
|
163886-93-9
|
C13H11BrN2O2
|
|
H-D-TYR-ILE-ASN-LEU-ILE-D-THR-ARG-GLN-ARG-D-TYR-NH2
|
163887-48-7
|
C61H99N19O15
|
|
2-hydroxypropanoic acid
|
163894-00-6
|
C3H6O3
|
|
3(8-,13 or 17)-(carboxyhydroxymethyl)-8,13,17(3,13,17-,3,8,17 or 3,8,13)-tris(carboxymethyl)-21H,23H-Porphine-2,7,12,18-tetrapropanoic acid
|
163894-01-7
|
C40H38N4O17
|
|
C,C,C,3-tetrakis(2-carboxyethyl)-C,C,C-tris(carboxymethyl)-21H,23H-Porphine-2-ethaneperoxoic acid
|
163894-02-8
|
C39H36N4O17
|
|
3,8,13-tris(carboxymethyl)-b2(b7-,b12 or b18)-hydroxy-17-methyl-21H,23H-Porphine-2,7,12,18-tetrapropanoic acid
|
163894-03-9
|
C39H38N4O14
|
|
SULFONYL CHLORIDE, POLYMER-BOUND
|
163894-16-4
|
C6H5ClO2S
|
|
myelin oligodendrocyte glycoprotein peptide fragment 35-55 rat, mouse
|
163913-87-9
|
C118H177N35O29S
|
|
1H-3-Benzazepin-2-aMine, 4,5-dihydro-
|
163914-97-4
|
C10H12N2
|
|
Carbamic acid, 5-(2,2-dimethyl-1,3-dioxolan-4-yl)-4-(phenylmethoxy)-1-(phenylmethyl)-3-pyrrolidinyl-, 1,1-dimethylethyl ester, 3S-3.alpha.,4.beta.,5.beta.(R*)-
|
163916-55-0
|
C28H38N2O5
|
|
Acetamide, N-5-1,2-bis(acetyloxy)ethyl-4-(phenylmethoxy)-1-(phenylmethyl)-3-pyrrolidinyl-, 3S-3.alpha.,4.beta.,5.beta.(R*)-
|
163916-56-1
|
C26H32N2O6
|
|
3-AMINO-3-FURAN-3-YL-PROPIONIC ACID ETHYL ESTER
|
163919-12-8
|
C9H13NO3
|